✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Quest Laboratories Ltd.

QUESTLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹143 Cr.
P/E
10.55

Quest Laboratories Ltd.

  • Quest Laboratories
  • Sotac Pharmaceutical
  • Auro Laboratories

FAQs on Quest Laboratories Ltd. Shareprice

Quest Laboratories has given lower returns compared to its competitors.
Quest Laboratories has grown at ~-24.48% over the last 1yrs while peers have grown at a median rate of -7.0%

Quest Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Quest Laboratories is 10.55, while 3 year average PE is 17.91.
Also latest EV/EBITDA of Quest Laboratories is 30.96 while 3yr average is 16.25.

View FAQ's On Business

Growth Table

  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Balance Sheet

  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Cash Flow

  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Quarterly Results

  • Quest Laboratories Ltd.
  • Sotac Pharmaceutical
  • Auro Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Quest Laboratories Ltd. Financials

Balance sheet of Quest Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Quest Laboratories is increasing.
Latest net debt of Quest Laboratories is ₹30.08 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹4.9 Crs.

The profit is oscillating.
The profit of Quest Laboratories is ₹5.58 Crs for TTM, ₹13.57 Crs for Mar 2025 and ₹10.09 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Quest Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech